Changes in the indications for scheduled births to reduce nonmedically indicated deliveries occurring before 39 weeks of gestation.

Obstet Gynecol

Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, and Center for Health Care Research and Policy, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio 44109, USA.

Published: August 2012

Objective: To estimate the change in indications for scheduled deliveries during the Ohio Perinatal Quality Collaborative's initiative to decrease scheduled deliveries for nonmedical indications before 39 weeks of gestation.

Methods: Documented indications for scheduled deliveries between 36 0/7 and 38 6/7 weeks were categorized as: strong medically accepted reasons for delivery; intermediate acceptability; and unnecessary before 39 weeks. We describe each of these indication categories as a proportion of all deliveries in the participating hospitals between October 2008 and December 2009.

Results: The percentage of scheduled deliveries that were unnecessary before 39 weeks or had intermediate indications decreased over time (P=.03). There were 145 fewer with intermediate reasons and 265 fewer that were unnecessary when the first 4 months of the project were compared with the last 4 months. Strong medical indications as a percentage of all deliveries did not change significantly over time (P=.99).

Conclusion: Our quality collaborative reduced scheduled deliveries of medically unnecessary and intermediate indications for delivery at 36 0/7 and 38 6/7 weeks. However, scheduled deliveries with strong medical indication did not change significantly over time.

Level Of Evidence: III.

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0b013e318260d9b2DOI Listing

Publication Analysis

Top Keywords

scheduled deliveries
24
indications scheduled
12
deliveries
9
0/7 6/7
8
6/7 weeks
8
unnecessary weeks
8
intermediate indications
8
strong medical
8
scheduled
7
weeks
6

Similar Publications

Background: Amyloid PET imaging is an established diagnostic tool for Alzheimer's disease, but its successful integration into clinical practice requires a comprehensive understanding of its impact on patients and the healthcare system. In 2022, the coverage with evidence development (CED) ENABLE study has been approved by the German Federal Joint Committee (trial registration: DRKS00030839). The study is scheduled to start in early 2024.

View Article and Find Full Text PDF

Background: Amyloid PET imaging is an established diagnostic tool for Alzheimer's disease, but its successful integration into clinical practice requires a comprehensive understanding of its impact on patients and the healthcare system. In 2022, the coverage with evidence development (CED) ENABLE study has been approved by the German Federal Joint Committee (trial registration: DRKS00030839). The study is scheduled to start in early 2024.

View Article and Find Full Text PDF

Background: Due to the high prevalence of depressive symptoms and dementia in older Americans (≥65 years), we trained unpaid family caregivers in an evidence-based life review depression intervention virtually via Zoom and produced positive outcomes. The objective of this study was to examine the feasibility of training caregivers via online video and delivering the intervention at home.

Method: We recruited caregiver-care recipient dyads nationwide during the COVID-19 pandemic (N = 20 dyads).

View Article and Find Full Text PDF

Background: Near-infrared spectroscopy (NIRS) enables a non-invasive measurement of tissue oxygen saturation (StO) in regions illuminated by near-infrared lights. Vascular occlusion test (VOT) serves as a model to artificially induce forearm ischemia-reperfusion. The combination of StO monitoring and VOT allows for dynamic evaluation of the balance between oxygen delivery and consumption in tissue, as well as the functional reserve of microcirculation.

View Article and Find Full Text PDF

Introduction: Cancer complicates approximately 1 in 2000 pregnancies, with increasing incidence due to factors such as increased maternal age, obesity and advancements in antenatal testing. Anaesthetists play a crucial role in managing pregnant patients with cancer, both during delivery and in providing anaesthesia for oncological treatments. This review explores the challenges in anaesthetic management and specific considerations for common cancers encountered in pregnant patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!